FABINO LIFE Fact Sheet, FABINO LIFE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FABINO LIFE Fact Sheet    (FABL)


Latest: Richa Agarwal's Top 3 Stocks for 2022 Revealed


Here is the latest financial fact sheet of FABINO LIFE . For more details, see the FABINO LIFE quarterly results and FABINO LIFE share price and chart. For a sector overview, read our pharmaceuticals sector report.

FABINO LIFE Price History

Price Rs 26.8
Mkt Cap Rs m 56
Vol '000 3.0
P/E X  
P/CF X 121.9
EPS (TTM) Rs 0.0
1 Day % 2.9
No. of shares m 2.10
1 Week % 2.9
1 Month % 2.5
1 Year % -
52 week H/L Rs 49.0/23.9
As on May 13, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

FABINO LIFE Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
FABINO LIFE  EQUITY SHARE DATA
High RsNANANA 
Low RsNANANA 
Sales per share (Unadj.) Rs184.1501.125.5 
Earnings per share (Unadj.) Rs04.60.3 
Diluted earnings per shareRs0.00.30.1 
Cash flow per share (Unadj.) Rs1.75.80.4 
Dividends per share (Unadj.) Rs000 
Adj. dividends per shareRs0.000.000.00 
Avg Dividend yield %000 
Book value per share (Unadj.) Rs40.344.910.9 
Adj. book value per shareRs2.93.26.2 
Shares outstanding (eoy) m0.150.151.20 
Bonus / Rights / Conversions  000 
Price / Sales ratio x000 
Avg P/E ratio x000 
P/CF ratio (eoy) x000 
Price / Book Value ratio x000 
Dividend payout %000 
Avg Mkt Cap Rs m000 
No. of employees `000NANANA 
Total wages/salary Rs m321 
Avg. sales/employee Rs Th000 
Avg. wages/employee Rs Th000 
Avg. net profit/employee Rs Th000 
FABINO LIFE  INCOME DATA
Net Sales Rs m287531 
Other income Rs m000 
Total revenues Rs m287531 
Gross profit Rs m331 
Depreciation Rs m000 
Interest Rs m320 
Profit before tax Rs m010 
Minority Interest Rs m000 
Prior Period Items Rs m000 
Extraordinary Inc (Exp) Rs m000 
Tax Rs m000 
Profit after tax Rs m010 
Gross profit margin %11.64.22.1 
Effective tax rate %106.730.528.8 
Net profit margin %00.91.0 
FABINO LIFE  BALANCE SHEET DATA
Current assets Rs m792920 
Current liabilities Rs m76176 
Net working cap to sales %9.116.347.9 
Current ratio x1.01.73.6 
Inventory Days Days77288 
Debtors Days Days3,3821,1301,585 
Net fixed assets Rs m772 
Share capital Rs m2212 
"Free" reserves Rs m551 
Net worth Rs m6713 
Long term debt Rs m1113 
Total assets Rs m853622 
Interest coverage x1.01.57.0 
Debt to equity ratio x0.21.60.2 
Sales to assets ratio x0.32.11.4 
Return on assets %3.47.61.6 
Return on equity %010.22.3 
Return on capital %39.617.23.1 
Exports to sales %000 
Imports to sales %000 
Exports (fob) Rs m000 
Imports (cif) Rs m000 
Fx inflow Rs m000 
Fx outflow Rs m000 
Net fx Rs m000 
FABINO LIFE  CASH FLOW
From Operations Rs m 2 24 -5 
From Investments Rs m -0 -0 -1 
From Financial Activity Rs m -2 -24 4 
Net Cashflow Rs m 0 1 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 56.8%
Institution 0.0%
Non-Institution 43.2%
Total 100.0%
Free Float 43.2%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off 105 1st Floor, Barodia Tower Plot No 12, D Block Central Market Prashant Vihar, New Delhi - 110085
E-mail info@fabinolife.com Web www.fabinolife.com
Tel 09883900021 / 09215324221 Fax
Sector PHARMACEUTICALS Group Private sector
Tr Agent Bigshare Services Pvt Ltd, Bharat Tin Works Building, 1st floor Opp. Vasant Oasis, Andheri (E)
CHM: Atul Kumar Jain COMP SEC: Jeel Poshiya YEAR OF INC: 2011 BSE CODE: 543444 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare FABINO LIFE With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

4 Reasons Why Sensex Rallied 1,345 Points Today(Closing)

After opening the day higher, Indian share markets extended gains as the session progressed and ended near the day's high.

Views on news

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK FABINO LIFE

  • Track your investment in FABINO LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FABINO LIFE

FABINO LIFE - BIOCON COMPARISON

COMPARE FABINO LIFE WITH

MARKET STATS